Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
Basic Tests for Drugs - Pharmaceutical Substances, Medicinal Plant Materials and Dosage Forms
(1998; 100 pages) [French] [Spanish] View the PDF document
Table of Contents
View the documentPreface
View the document1. Introduction
View the document2. Other collections of simple tests
View the document3. Test procedures for pharmaceutical substances
View the document4. Test procedures for medicinal plant materials
View the document5. Test procedures for pharmaceutical dosage forms
View the document6. Reagents
View the documentAcknowledgements
View the documentOther WHO publications on pharmaceuticals
View the documentBack cover
 

Acknowledgements

Acknowledgements are made to the following persons who have collaborated in establishing and verifying the procedures described in this document:

Professor H.Y. Aboul-Enein, Drug Development Laboratory, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia; Professor I. Addae-Mensah, Department of Chemistry, University of Ghana, Legon-Accra, Ghana; Dr E.O.P. Agbakwuru, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Benin, Benin City, Nigeria; Dr S.L. Ali, Association of German Pharmacists’ Central Laboratory, Eschborn, Germany; Mr J.P. Billon, Rhône-Poulenc, Centre de Recherches, Vitry-sur-Seine, France; Professor P.F. Coville, University of Otago, Dunedin, New Zealand; Professor D. Dobrescu, State Institute for Drug Control and Pharmaceutical Research, Bucharest, Romania; Professor M.P. Gupta, University of Panama, Panama; Dr A.I. Hag Omer, Drug Quality Control, National Chemical Laboratories, Ministry of Health, Khartoum, Sudan; Dr P. Hayes, University of Otago, Dunedin, New Zealand; Professor A.W.M. Indemans, Laboratory of the Dutch Pharmaceutical Society, The Hague, Netherlands; Dr Z.A. Jan, Drugs Control and Research Division, National Institute of Health, Islamabad, Pakistan; Dr A. Kaukinen, National Medicines Control Laboratory, Helsinki, Finland; Dr K. Kawamura, Production Division, Takeda Chemical Industries, Ltd, Tokyo, Japan; Dr Ng Tju Lik, Department of Scientific Services, Institute of Science and Forensic Medicine, Singapore; Dr J.D. Nicholson, Medicines Testing Laboratory, Edinburgh, Scotland; Professor A.A. Olaniyi, Department of Pharmaceutical Chemistry, College of Medicine, Faculty of Pharmacy, University of Ibadan, Ibadan, Nigeria; Dr P.R. Pabrai, Corporate Quality Assurance, Ranbaxy Laboratories Ltd, New Delhi, India; Dr M. Pesez, Roussel-Uclaf SA, Romainville, France; Professor M. Rafiee-Tehrani, Industrial Pharmacy Research Laboratory, College of Pharmacy, Teheran University of Medical Sciences, Teheran, Islamic Republic of Iran; Professor J. Richter, Berlin, Germany; Dr P.D. Sethi, Central Indian Pharmacopoeia Laboratory, Ghaziabad, India; Dr S.C. Sharma, Central Indian Pharmacopoeia Laboratory, Ghaziabad, India; Ms K. Sinivuo, National Agency for Medicines, Helsinki, Finland; Dr R. Soliman, Alexandria, Egypt; Professor Tu Guoshi, Division of Pharmaceutical Chemistry, National Institute for the Control of Pharmaceutical and Biological Products, Ministry of Health, Beijing, China; Professor L. Turakka, National Medicines Control Laboratory, Helsinki, Finland; Mrs O. Van Berkel-Geldof, National Institute for Drug Control, Leiden, Netherlands; Dr M. Vernengo, PAHO/WHO, National Institute of Quality Control and Health, Rio de Janeiro, Brazil; Dr I. Vukušiæ, Podravka-Food, Pharmaceutical and Cosmetic Industry, Zagreb, Croatia; Dr W. Wieniawski, Institute of Drug Research and Control, Warsaw, Poland.

Thanks are also extended to the following WHO Collaborating Centres and national institutions:

WHO Collaborating Centre for Drug Quality Assurance, National Institute for the Control of Pharmaceutical and Biological Products, Ministry of Health, Beijing, China; WHO Collaborating Centre for Stability Studies of Drugs, Regional and University Hospital Centre, Nantes, France; WHO Collaborating Centre for Drug Information and Quality Assurance, National Institute of Pharmacy, Budapest, Hungary; WHO Collaborating Centre for Quality Assurance of Essential Drugs, Central Drugs Laboratory, Calcutta, India; WHO Collaborating Centre for Quality Assurance of Essential Drugs, Drug Analysis Division, Nonthaburi, Thailand; State Institute for Drug Control, Prague, Czech Republic; Quality Control Department, Mexican Institute of Social Security, Mexico City, Mexico; Central Indian Pharmacopoeia Laboratory, Ghaziabad, India; Food and Drug Administration, Ministry of Public Health, Nonthaburi, Thailand.

 

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: November 5, 2014